Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis

NCT02376972 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
392
Enrollment
INDUSTRY
Sponsor class

Stopped According to the Recommendation of the Indipendent Data Monitoring Committee

Conditions

Interventions

Sponsor

Alfasigma S.p.A.

Collaborators